Structure, localization, and regulation of cGMP-inhibited phosphodiesterase (PDE3) (Q28115585)

3 January 2017

1 reference

Europe PubMed Central

title

Structure, localization, and regulation of cGMP-inhibited phosphodiesterase (PDE3) (English)

1 reference

3',5'-cyclic-nucleotide phosphodiesterase activity

3 January 2017

1 reference

GOA release 2020-03-11

1 reference

GOA release 2020-03-11

author name string

E. Degerman

series ordinal

1

1 reference

3 January 2017

P. Belfrage

series ordinal

2

1 reference

3 January 2017

V. C. Manganiello

series ordinal

3

1 reference

3 January 2017

language of work or name

English

0 references

publication date

14 March 1997

1 reference

Journal of Biological Chemistry

3 January 2017

published in

1 reference

3 January 2017

volume

272

1 reference

3 January 2017

issue

11

1 reference

3 January 2017

page(s)

6823–6826

1 reference

Diversity in cyclic nucleotide phosphodiesterase isoenzyme families

3 January 2017

cites work

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.11.6823

Identification of a conserved domain among cyclic nucleotide phosphodiesterases from diverse species

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.11.6823

Nitric oxide regulates the calcium current in isolated human atrial myocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.11.6823

Primary sequence of cyclic nucleotide phosphodiesterase isozymes and the design of selective inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.11.6823

Cyclic nucleotide phosphodiesterases: pharmacology, biochemistry and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.11.6823

A new generation of phosphodiesterase inhibitors: multiple molecular forms of phosphodiesterase and the potential for drug selectivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.11.6823

Type III cGMP-inhibited cyclic nucleotide phosphodiesterases (PDE3 gene family)

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.11.6823

Molecular cloning and expression of human myocardial cGMP-inhibited cAMP phosphodiesterase

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.11.6823

Multiple transcripts for the human cardiac form of the cGMP-inhibited cAMP phosphodiesterase

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.11.6823

Distinctive anatomical patterns of gene expression for cGMP-inhibited cyclic nucleotide phosphodiesterases

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.11.6823

Characterization of two recombinant PDE3 (cGMP-inhibited cyclic nucleotide phosphodiesterase) isoforms, RcGIP1 and HcGIP2, expressed in NIH 3006 murine fibroblasts and Sf9 insect cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.11.6823

Evidence that insulin and isoprenaline activate the cGMP-inhibited low-Km cAMP phosphodiesterase in rat fat cells by phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.11.6823

cAMP-mediated phosphorylation of the low-Km cAMP phosphodiesterase markedly stimulates its catalytic activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.11.6823

Purification and properties of the cGMP-inhibited cAMP phosphodiesterase from bovine aortic smooth muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.11.6823

Roles of ATP in insulin actions

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.11.6823

Increasing cAMP attenuates activation of mitogen-activated protein kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.11.6823

Association of protein kinase A and protein phosphatase 2B with a common anchoring protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.11.6823

Antilipolytic action of insulin: role of cAMP phosphodiesterase activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.11.6823

cAMP compartmentation is responsible for a local activation of cardiac Ca2+ channels by beta-adrenergic agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.11.6823

Type III Phosphodiesterase Plays a Necessary Role in the Growth-Promoting Actions of Insulin, Insulin-Like Growth Factor-I, and Ha p21rasinXenopus laevisOocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.11.6823

Hormone sensitive phosphodiesterase of liver and adipose tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.11.6823

Activation and phosphorylation of the 'dense-vesicle' high-affinity cyclic AMP phosphodiesterase by cyclic AMP-dependent protein kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.11.6823

21 January 2018

Identifiers

DOI

10.1074/JBC.272.11.6823

1 reference

Consolidated OpenCitations Corpus – April 2017

1 reference

Consolidated OpenCitations Corpus – April 2017

1 reference

Consolidated OpenCitations Corpus – April 2017